granulés pour solution buvable en sachet

DRUG3 trials

Sponsors

CHU De Rouen, Centre Hospitalier Universitaire De Lille, Assistance Publique Hopitaux De Paris

Conditions

Male Urinary Tract InfectionPatients (male or female) ≥18 years old with Detrusor overactivity (DO) in multiple sclerosis (MS) or spinal cord injured (SCI).Women aged 75 years or older presenting with E. coli pyelonephritis

Phase 3

Exploratory Pragmatic trial of fosfomycin-trometamol treatment of male urinary tract infections in primary care.

Not yet recruitingCTIS2023-510355-36-00

CHU De RouenMale Urinary Tract Infection

Target: 110Updated: 2024-10-18

ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoing intra-vesical botulinum toxin A injections

Not yet recruitingCTIS2024-515107-19-00

Centre Hospitalier Universitaire De LillePatients (male or female) ≥18 years old with Detrusor overactivity (DO) in multiple sclerosis (MS) or spinal cord injured (SCI).

Target: 526Updated: 2025-11-10

FOSFOLD - Fosfomycin trometamol compared with another active antibiotic relay therapy for the treatment of acute Escherichia coli pyelonephritis in elderly women: a randomized, multicenter, non-inferiority trial

Not yet recruitingCTIS2025-521663-13-00

Assistance Publique Hopitaux De ParisWomen aged 75 years or older presenting with E. coli pyelonephritis

Target: 312Updated: 2026-08-21